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Molecular Evidence for Zoonotic Transmission of an Emergent, Highly
Pathogenic Campylobacter jejuni Clone in the United States
Abstract
Campylobacter jejuni is a major zoonotic pathogen. A highly virulent, tetracycline-resistant C. jejuni clone
(clone SA) has recently emerged in ruminant reservoirs and has become the predominant cause of sheep
abortion in the United States. To determine whether clone SA is associated with human disease, we compared
the clinical isolates of clone SA from sheep abortions with the human isolates of the PulseNet National
Campylobacter databases at the CDC and the FDA using pulsed-field gel electrophoresis (PFGE), multilocus
sequence typing (MLST), and serotyping. The combined SmaI and KpnI PFGE pattern designations of clone
SA from sheep were indistinguishable from those of 123 (9.03%) human C. jejuniisolates (total, 1,361) in the
CDC database, among which 56 were associated with sporadic infections and 67 were associated with
outbreaks that occurred in multiple states from 2003 to 2010. Most of the outbreaks were attributed to raw
milk, while the sources for most of the sporadic cases were unknown. All clone SA isolates examined,
including PFGE-matched human isolates, belong to sequence type 8 (ST-8) by MLST and serotype HS:1,8,
further indicating the clonality of the related isolates from different host species. Additionally, C. jejuni clone
SA was identified in raw milk, cattle feces, the feces and bile of healthy sheep, and abortion cases of cattle and
goats, indicating the broad distribution of this pathogenic clone in ruminants. These results provide strong
molecular and epidemiological evidence for zoonotic transmission of this emergent clone from ruminants to
humans and indicate that C. jejuni clone SA is an important threat to public health.
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Campylobacter jejuni is a major zoonotic pathogen. A highly virulent, tetracycline-resistant C. jejuni clone (clone SA) has re-
cently emerged in ruminant reservoirs and has become the predominant cause of sheep abortion in the United States. To deter-
mine whether clone SA is associated with human disease, we compared the clinical isolates of clone SA from sheep abortions
with the human isolates of the PulseNet National Campylobacter databases at the CDC and the FDA using pulsed-field gel elec-
trophoresis (PFGE), multilocus sequence typing (MLST), and serotyping. The combined SmaI and KpnI PFGE pattern designa-
tions of clone SA from sheep were indistinguishable from those of 123 (9.03%) human C. jejuni isolates (total, 1,361) in the CDC
database, among which 56 were associated with sporadic infections and 67 were associated with outbreaks that occurred in mul-
tiple states from 2003 to 2010. Most of the outbreaks were attributed to rawmilk, while the sources for most of the sporadic cases
were unknown. All clone SA isolates examined, including PFGE-matched human isolates, belong to sequence type 8 (ST-8) by
MLST and serotype HS:1,8, further indicating the clonality of the related isolates from different host species. Additionally, C.
jejuni clone SA was identified in rawmilk, cattle feces, the feces and bile of healthy sheep, and abortion cases of cattle and goats,
indicating the broad distribution of this pathogenic clone in ruminants. These results provide strong molecular and epidemio-
logical evidence for zoonotic transmission of this emergent clone from ruminants to humans and indicate that C. jejuni clone SA
is an important threat to public health.
Campylobacter jejuni is a leading cause of bacterial food-bornegastroenteritis worldwide and is a major public health prob-
lem (1, 2, 57). As reported by the Centers for Disease Control and
Prevention (CDC) FoodNet surveillance program in 2009, Cam-
pylobacter ranked second (13.02 per 100,000 population) only to
Salmonella (15.19 per 100,000 population) among the causes of
laboratory-confirmed bacterial food-borne illnesses in the United
States (9). A very recent estimate by theCDC further indicates that
Campylobacter is not only among the most common causes of
domestically acquired food-borne illnesses in humans (over
800,000 cases per year), but also is among the leading causes of
hospitalization (over 8,000 annually) in the United States (49).
Campylobacter infections in humans are usually characterized by
self-limiting watery/bloody diarrhea, abdominal cramps, nausea,
and fever; however, severe neurological sequelae, bacteremia, and
other extraintestinal complications may develop infrequently (4,
42). Antibiotic therapy with fluoroquinolones or macrolides may
be required for patients with severe or chronic infections (4).
As a zoonotic pathogen, Campylobacter is widespread in food-
producing animals, and thus, foods of animal origin are fre-
quently contaminated with the organism. The majority of Cam-
pylobacter infections in humans are sporadic and predominantly
associated with poor handling of raw chicken or consumption of
undercooked chicken (17, 19, 23, 24). Other risk factors include
contact with house pets, exposure to farm animals, and the con-
sumption of raw milk, untreated water, and undercooked beef,
pork, and shellfish (3, 19). Outbreaks due to Campylobacter are
most commonly associated with consumption of raw milk, con-
taminated surface water, and chickenmeat (3, 24, 27, 28). Despite
the prominent role of poultry in the transmission of campylobac-
teriosis, recentmolecular epidemiological studies indicate that ru-
minants also contribute significantly to both sporadic cases and
the outbreak of human infections via contaminated milk, water,
and produce (11, 14, 30, 32, 41).
Pathogens constantly evolve in response to selective pressures,
and adaptation leads to the emergence and spread of new patho-
genic variants and clones (34, 58). Recently, we discovered that a
highly virulent C. jejuni clone (clone SA, for sheep abortion) has
emerged as the predominant cause of Campylobacter-associated
abortion in sheep in the United States (48). This finding repre-
sents a paradigm shift, because diverse Campylobacter species and
strains were responsible for sheep abortion in the United States
prior to the predominance of clone SA (15). All isolates of clone
SA were resistant to tetracycline (48), the only class of antibiotics
that is approved for use in treating sheep abortion and which is
commonly used for prevention and control of the disease in the
United States. These findings suggest that tetracycline use might
have facilitated, at least partially, the emergence and spread of
clone SA. The high virulence of clone SA in causing abortion was
confirmed using a pregnant-guinea-pig model, in which the dis-
tinct abortifacient ability of the clone was shown compared with
other C. jejuni strains (7).
In a previous study (48), we noticed that the multilocus se-
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quence typing (MLST) type (ST-8) of clone SA was identical to
that of several human C. jejuni isolates that were in the Campylo-
bacterMLST database (http://pubmlst.org/campylobacter/). This
circumstantial evidence suggested that clone SA may also cause
disease in the human host. To evaluate this possibility, we compared
the pulsed-field gel electrophoresis (PFGE) profiles of clone SA with
those of human C. jejuni isolates deposited in the PulseNet National
Campylobacter database at the CDC (www.cdc.gov/pulsenet
/pathogens_pages/campylobacter_jejuni.htm). In addition, the pres-
ence of clone SA in different types of retail meats was investigated by
comparisonwith the PFGE database at the Food andDrugAdminis-
tration (FDA) (http://www.fda.gov/cvm/default.html). Finally, we
determined the prevalence of clone SA in animal reservoirs by sur-
veying a lamb slaughterhouse.
MATERIALS AND METHODS
Sources of Campylobacter isolates for typing. The source of C. jejuni
isolates obtained fromovine abortion cases was described previously (48).
Among the PFGE-matched isolates, two human isolates (FDA 17848 and
FDA 17817) and two chicken isolates (FDA N337 and FDA N342) were
obtained from theCenter for VeterinaryMedicine at the FDA for analysis,
and 27 human C. jejuni isolates were obtained by the National Campylo-
bacter and Helicobacter Reference Laboratory at the CDC from the Wyo-
ming State Public Health Laboratory (n  4), Colorado State Public
Health Laboratory (n 1), South Dakota State Public Health Laboratory
(n 19), and Kansas State Public Health Laboratory (n 3) for molec-
ular typing by MLST. Also, C. jejuni isolates associated with cattle abor-
tions from California (n  9; between 2003 and 2005), Iowa (n  3;
between 2006 and 2009), and North Dakota (n 1; 2005) and goat abor-
tions from Iowa (n  14; between 2004 and 2010) were included for
molecular typing. Additionally, 48 C. jejuni isolates from healthy sheep
were analyzed by MLST and PFGE.
PFGE.PFGEusing SmaI andKpnI restriction enzymeswas performed
following the CDC’s standardized PulseNet protocol for C. jejuni (46).
The PFGEpatterns of clone SAwere comparedwith those of the humanC.
jejuni isolates deposited in the PulseNet NationalCampylobacter database
at the CDC to determine the genetic relatedness between the isolates from
animals and humans. The FDA’s PFGE database was interrogated for
possiblematches to retailmeatC. jejuni isolates. PFGEwas also performed
on the slaughterhouse isolates to determine the prevalence of clone SA in
healthy animals. The gel patterns were analyzed with the BioNumerics
v.4.01 software program (Applied Maths, Kortrijk, Belgium) using the
Dice similarity coefficient with 0.5% optimization and 1.0 to 1.25% posi-
tion tolerance. The strains were clustered by the unweighted-pair group
method using average linkages (UPGMA) to reflect similarities. Isolates
whose restriction profiles had a similarity coefficient of90% were con-
sidered a PFGE cluster having closely related (clonal) genotypes, as de-
scribed elsewhere (45).
MLST. MLST for C. jejuni (http://pubmlst.org/campylobacter/) was
performed as described elsewhere (16, 48) on representative C. jejuni iso-
lates from different sources to further confirm the strain relatedness. Of
the 123 human isolates in the PulseNet National Campylobacter database
that were indistinguishable by PFGE from clone SA subtypes I and II, 27
(obtained from the four State Public Health Laboratories mentioned
above) were available for MLST analysis. MLST was also performed to
determine the genetic diversity amongC. jejuni isolates obtained from the
lamb slaughterhouse. The standardized index of association (IAs) between
different MLST loci and the mean genetic diversity (H, which reflects
allelic diversity across all loci and ranges from0 to 1)were calculated using
the LIAN program version 3.5 (31). If there is complete linkage equilib-
rium (statistical independence of alleles at all loci), the IAs is equal to zero
(as it is within a freely recombining population); on the other hand, this
value is significantly different from zero for populations with a clonal
structure, where significant linkage disequilibrium exists (a value of 1
indicates absolute linkage disequilibrium).
The eBURST program (version 3) with the default settings (where STs
within the same group share identical alleles at6 of the 7MLST loci with
at least one other ST in the group) was used to depict the evolutionary
relationships within all the ST-21 complex isolates, which includes ST-8,
present in the CampylobacterMLST database (20).
Serotyping. Penner heat-stable (HS) serotyping was performed using
a panel of antisera, as described elsewhere (21), on four representative C.
jejuni isolates of clone SA. The four isolates were IA5908 and IA3902
(from sheep abortions; subtypes I and II based on the KpnI restriction
pattern, respectively), FDA 17848 (from human gastroenteritis), and
1E2B2a (from bile of healthy sheep). These C. jejuni isolates were of the
sameMLST genotype (ST-8) and had nearly indistinguishable PFGE pat-
terns (shown in Fig. 1 and 2). They were chosen for serotyping because
they have the same MLST sequence type (ST-8) and very close (but not
identical) PFGE patterns but were isolated from diverse sources.
Distribution of clone SA in healthy sheep. To help understand the
distribution of C. jejuni clone SA in animal reservoirs, we conducted a
survey to determine if the clone was present in healthy sheep. A local
abattoir slaughtering lambs from multiple states (Iowa, Idaho, Kansas,
Minnesota,Missouri, Nebraska, and SouthDakota) was visited twice dur-
ing the fall of 2008 to collect samples. On each sampling day, small-
intestine contents and bile were obtained from randomly chosen carcasses
soon after evisceration. Depending on the sizes of the lots, 3 to 10 speci-
mens for each sample type were collected from different animals within
the same lot (defined as a cohort of animals from a particular farm). In
total, 103 intestinal contents and 124 bile samples (from 22 different lots)
were obtained. Direct plating was used for isolation of Campylobacter
from bile samples, while both direct plating and enrichment were em-
ployed with the intestinal contents (47, 56). Campylobacter-like colonies
were selected, and a single isolate from each sample was subjected to
species identification by PCR (36, 47) and molecular typing by PFGE and
MLST, as described above.
Antimicrobial susceptibility testing.A standard brothmicrodilution
test, as recommended by the CLSI and the National Antimicrobial Resis-
tanceMonitoring System for Enteric Bacteria (NARMS) (8, 12), was used
for the antimicrobial susceptibility test on the C. jejuni isolates from the
sheep slaughterhouse and was conducted using commercially available
SensititreCampylobacter plates (TrekDiagnostics, Cleveland,OH), which
include nine antimicrobial agents.
RESULTS
Association of clone SA with human infections. Based on the
PFGE patterns, clone SA has a single SmaI type and two closely
related KpnI subtypes, I (lanes 2,3,4 and 5) and II (lanes 6 and
7), as shown in Fig. 1 and in our previous study (48). According
to the PulseNet designations for PFGE profiles, the SmaI pat-
tern of clone SA is DBRS16.0008, while the KpnI patterns for
subtypes I and II are DBRK02.0148 and DBRK02.0028, respec-
tively. The combined pattern designation of DBRS16.0008 and
DBRK02.0028 has been seen 76 times among human isolates in
the PulseNet National database at the CDC, amongwhich 42 were
from sporadic infections and 34 were associated with outbreaks
(no. 2, 3, 4, 5, 7, and 9) (Table 1). These cases occurred inmultiple
states (Arkansas, Colorado, Kansas, Michigan, Pennsylvania,
Rhode Island, South Carolina, South Dakota, Utah, Vermont,
Wisconsin, and Wyoming) from 2004 to 2010 (Table 1). Addi-
tionally, the combined pattern designation of DBRS16.0008 and
DBRK02.0148 had exact matches to 47 human C. jejuni isolates,
14 of which were from sporadic infections (occurring in Massa-
chusetts, South Dakota, Utah, and Wisconsin between 2004 and
2010) and 33were associatedwith outbreaks (no. 1, 5, 6, 9, and 10)
in the PulseNet national database at the CDC (Table 1). Two out-
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breaks (no. 5 and 9) had both pattern combinations associated
with them. Most of the outbreak cases were related to raw milk
(Table 1). Altogether, the combined SmaI andKpnI PFGE pattern
designations of clone SA were indistinguishable from those of 123
human C. jejuni isolates (representing 9.03% of 1,361 human C.
jejuni isolates in the CDC database), 56 of which were from spo-
radic infections while 67 were associated with outbreaks known in
the PulseNet database through 2010. Although limited epidemio-
logical information is available on the matches, most implicated
cases were gastroenteritis, and only two had evidence of systemic
(blood) infection (Table 1). In addition to these human isolates,
two C. jejuni isolates with pattern designations DBRS16.0008 and
DBRK02.0028 were from raw-milk samples purchased from an
implicated dairy during the 2008 outbreak that occurred in Penn-
sylvania (Table 1). Twenty-seven of the 56 sporadic human C.
jejuni isolates were available for further characterization byMLST;
all 27 isolates were ST-8.
In total, nine C. jejuni isolates from the FDA database (which
comprised over 3,000 Campylobacter isolates at the time of the
database search) showed matches with clone SA, among which
seven, from retail chickenmeat (all fromMinnesota in 2004), had
a combined SmaI-KpnI restriction pattern indistinguishable from
that of clone SA subtype I. The remaining two isolates were of
human origin (both from Iowa) and had PFGE profiles identical
or closely related to that of clone SA subtype I. To further confirm
their relationship to clone SA, four of the FDA isolates, two from
chickens and two from humans, were subjected to PFGE and
MLST. All 4 isolates had the same SmaI restriction profile as the
SA clone (Fig. 1A). With respect to the KpnI restriction pattern
(Fig. 1B), both chicken isolates (lanes 3 and 4) and one of the
human isolates (lane 2)were indistinguishable from clone SA sub-
type I (lane 5), whereas the other human isolate (lane 1) had a
single-band difference from subtype I. All of the isolates had the
same MLST type, ST-8.
Isolates of clone SAbelong to serotypeHS:1,8.Four represen-
tative C. jejuni clone SA isolates were examined using the Penner
HS scheme, which identified all of them as HS:1,8. The four iso-
lates were IA5908 and IA3902 (both from sheep abortions), FDA
17848 (fromhuman gastroenteritis), and 1E2B2a (from the bile of
a healthy sheep). These isolates are either indistinguishable from
or very closely related (a single-band difference) to the PFGE sub-
type of clone SA (Fig. 1 and 2), and all belong to ST-8 by MLST.
Presence of clone SA in nonsheep ruminants. Of the 13 C.
jejuni isolates associated with cattle abortions, 5 (38%) were iden-
tified as clone SA byMLST (ST-8) and PFGE, 3 of which occurred
inCalifornia between 2003 and 2004, one in Iowa in 2009, and one
in North Dakota in 2005 (results not shown). Out of the 14 total
goat abortion isolates, 6 (43%; all from Iowa between 2004 and
2010) were identified as clone SA by PFGE (partly shown in Fig. 1)
andMLST (ST-8; results not shown). In addition, there were 18C.
jejuni isolates with PFGE matches identical to those of clone SA
from nonhuman sources (15 bovine and 3 ovine) in the PulseNet
National Campylobacter database at the CDC from 2003 to 2010.
Of these, 14 were from bovine stool samples investigated during
raw-milk outbreaks that occurred in Wisconsin, Massachusetts,
and Vermont in 2009 and 2010. These findings indicate that C.
jejuni clone SA is broadly distributed in the ruminant reservoirs.
Presence of clone SA in healthy sheep. Of the 103 small-
intestine contents and 124 bile samples collected from a lamb
slaughterhouse,Campylobacterwas isolated from45 (44%) and 14
(11%) of the samples, respectively. Most of the isolates were C.
jejuni (n  48), and the remaining ones were C. coli (n  7); 4
Campylobacter isolates were not recovered from frozen stocks in
subsequent passages. A total of 14 different STs were identified
among the 48 C. jejuni isolates, indicating a substantial level of
genetic diversity and revealing the presence of ST-8 (n 6; 12.5%)
in healthy sheep (Fig. 2). The ST-8 isolates were from both bile
FIG 1 PFGE analysis of C. jejuni isolates from different sources using SmaI (A) or KpnI (B). The isolates were FDA 17848 and FDA 17817 (lanes 1 and 2; from
human), FDA N337 and FDA N342 (lanes 3 and 4; from chicken), clone SA subtype I (IA5908; lane 5) and subtype II (IA3902; lane 6), a goat abortion isolate
(IA625; lane 7), and C. jejuni NCTC 11168 (lane 8). M, size marker (Salmonella sp. strain Braenderup H9812 genomic DNA digested with XbaI).
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(n 3) and intestinal contents (n 3) collected from four differ-
ent lots.
PFGE typingwithKpnI on the 48C. jejuni isolates generated 17
major PFGE types at a 90% similarity cutoff level, representing 23
unique macrorestriction profiles (Fig. 2). Notably, the six ST-8
isolates had SmaI andKpnI PFGE patterns indistinguishable from
or highly similar (ca. 95% genetic similarity) to those of clone SA
(Fig. 2). This finding and the MLST result indicated that C. jejuni
clone SA is present in clinically healthy animals in both intestinal
contents and bile.
The IAs (reflecting the degree of clonality in a population) for
the entire group of C. jejuni isolates from the slaughterhouse was
0.4358 (P  0.01), indicating the presence of significant linkage
disequilibrium for the alleles fromdifferent loci. This finding, plus
the relatively high level of mean genetic diversity (H 0.7055
0.0306), indicates that the C. jejuni population from the lamb
slaughterhouse showed a moderate level of clonality with a low
level of recombination between different strains. These values are
in overall agreement with the population structure of Campylo-
bacter from different sources (16, 29).
The vast majority of C. jejuni isolates derived from the sheep
slaughterhouse (ca. 84%; n  40) were resistant to tetracycline,
with a MIC90 of 64 g/ml (Table 2). All of the ST-8 slaughter-
house isolates (n  6) were resistant to tetracycline (MIC  64
g/ml), consistent with other clone SA isolates reported previ-
ously (48). The sheep slaughterhouse isolates were generally sus-
ceptible to the rest of the antibiotics tested in this study (Table 2).
Evolution of the ST-8 genotype.The ST-21 complex comprises
C. jejuni isolates fromdiverse sources, such as humans, farm animals
(cattle, sheep, and poultry), wild birds, and the environment, includ-
ing ST-8 strains (http://pubmlst.org/campylobacter/). eBURSTanal-
ysis of the entire ST-21 complex isolates present in theCampylobacter
MLST database as of February 2010 was performed to provide clues
to the evolutionary descent and the emergence of the ST-8 genotype,
towhich isolates of clone SAbelong. The analysis assigned 393 STs to
two eBURST-based clonal groups (STs sharing identical alleles at six
ormoreof the sevenMLST loci) and34STs as singletons (STs that do
not share at least six out of seven loci with any other STs in the data
set). The largest clonal group comprised 357 STs representing 1,144
isolates, ofwhich the founding genotypewas ST-21, and included the
isolates within ST-8 (Fig. 3). The founder (ST-21) of this eBURST
groupdiffers fromST-8 at only one locus, and the only difference is a
single-nucleotide polymorphism in the uncA gene (data not shown).
These analyses suggest that ST-8 originated from ST-21. Also, ST-8
itself is a predicted founder of a much smaller subgroup comprising
four STs that each differed from ST-8 at a single locus (Fig. 3).
DISCUSSION
Many pathogenic bacteria comprise a population structure in
which several highly successful genetic lineages predominate for a
TABLE 1 Human C. jejuni isolates indistinguishable by PFGE from
clone SA identified in the PulseNet National Campylobacter database at
the CDC through 2010
Case
No. of
isolates State Yr
Isolation
source Exposure
Outbreak 1 1 VT 2003 Unknown Raw milk
Outbreak 2 4 SC 2007 Stool Raw milk
Outbreak 3 16a PA 2008 Unknown Raw milk
Outbreak 4 4 RI 2008 Unknown Chicken
Outbreak 5 32 WI 2009 Stool Raw milk
Outbreak 6 2 MA 2010 Stool/blood Raw milk
Outbreak 7 7 MI 2010 Stool Raw milk
Outbreak 8 1 MT 2010 Unknown Well water
Outbreak 9 2 VT 2010 Stool Raw milk
Sporadicb 56 Multiple 2004–2010 Stool Unknown
a Includes two raw milk isolates from the dairy implicated in the outbreak.
b Sporadic cases were from multiple states (Arkansas, Colorado, Kansas, Massachusetts,
Utah, Sout Dakota, Vermont, Wisconsin, and Wyoming); the isolates were mainly from
stool samples (except a few from blood or unknown origin), and sources of exposure
were unknown for most cases (raw milk was implicated in one case).
FIG 2 PFGE-based dendrogram depicting the relatedness of 48 C. jejuni iso-
lates from a lamb slaughterhouse. Strain names and STs are given next to the
restriction profiles. The components of the strain prefixes, from left to right,
are as follows: number 1 or 2, sampling occasion; E or L, ewe or lamb, respec-
tively; lot number; B or F, bile or fecal sample, respectively; sample number; a
or b, identifier of the C. jejuni colony when multiple colonies from the same
sample were saved.
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certain time and are associated with the majority of a particular
disease syndrome (6, 34). Although theCampylobacter population
exhibits certain structured clonal diversity and some serotypes are
associated with a particular disease outcome (e.g., Guillain-Barré
syndrome), no particular genetic clones have been linked to a
specific disease or severity of illness (10). However, our recent
work demonstrated the emergence of the highly virulent C. jejuni
clone SA associated with sheep abortion in the United States (7,
48). In the present study, we further demonstrated the association
of clone SA with human disease, including multiple outbreak
cases of human gastroenteritis linked mainly to raw-milk con-
sumption (Table 1). This finding provides compelling evidence
for zoonotic transmission of this pathogenic clone from animals
to humans. Epidemiologically, contaminated chickenmeat is rec-
ognized as a main source of human Campylobacter infections;
however, the significance of the ruminant reservoir in Campylo-
bacter transmission is increasingly recognized (13, 14, 28, 51, 59).
The results from this study further highlight the importance of
TABLE 2 Antimicrobial susceptibilities of 48 C. jejuni isolates from a sheep slaughterhouse as determined by a broth microdilution test
Antibiotic Range tested (g/ml)
MIC (g/ml)
Resistance
breakpoint (g/ml)a
No. (%) of
resistant isolatesRange 50% 90%
Azithromycin 0.015–64 0.03–0.12 0.06 0.12 8 0 (0)
Ciprofloxacin 0.015–64 0.06–16 0.12 0.12 4 2 (4.1)
Clindamycin 0.03–16 0.06–1 0.12 0.25 8 0 (0)
Erythromycin 0.03–64 0.25–2 0.5 1 32 0 (0)
Florfenicol 0.03–64 0.5–4 1 1 16 0 (0)
Gentamicin 0.12–32 0.25–2 0.5 1 8 0 (0)
Nalidixic acid 4–64 4–64 4 8 32 3 (6.2)
Telithromycin 0.015–8 0.25–2 1 1 16 0 (0)
Tetracycline 0.06–64 0.25–64 64 64 16 40 (83.3)
a Based on references 8 and 12.
FIG 3 eBURST diagram depicting the evolutionary descent of the entire ST-21 complex in the CampylobacterMLST database. The database was accessed on 10
February 2010. The largest eBURST groupwith the default group definition (six of seven shared alleles), inwhich all STs are single locus variants of least one other
ST in the group, is displayed. Each circle denotes an ST (only the major ones are shown for clarity), and the size of the circle is proportional to the number of
isolates present in that genotype. Group and subgroup founders are shown as blue and yellow circles, respectively. The predicted group founder (ST-21; 99%
bootstrap support) and clone SA (ST-8) are labeled.
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ruminantCampylobacter in public health andunderscore the need
for enhanced efforts in the surveillance and investigation of rumi-
nant sources for better control of the zoonotic transmission of
Campylobacter.
Based on MLST analysis, certain clonal complexes and STs of
C. jejuni are overrepresented within a particular host species (10,
35, 38, 39, 45, 50). For example, ST-21 is frequently observed in
human, ruminant, and poultry isolates (29, 35, 45), but ST-61 and
ST-42 are most common among cattle and sheep isolates (22, 40,
50). A recent study of C. jejuni strains isolated from chickens,
cattle, and sheep showed that ST-8 was found only among sheep
and cattle populations ofCampylobacter (39). Clone SA belongs to
ST-8, but not all ST-8 isolates are necessarily clone SA, since a
single ST type may harbor divergent genotypes, as determined by
more discriminatory typing methods, such as PFGE. Considering
the facts that clone SA has recently become the predominant cause
of sheep abortion in the United States (48, 53) and that multiple
human cases associated with clone SA have been identified in re-
cent years (the increasing number of matches to clone SA are
shown in Table 1), it is tempting to speculate that the cross-species
transmission (from ruminants to humans) ofC. jejuni clone SA in
the United States might be a recent event. This possibility cannot
be ascertained from the PulseNet database, because limited infor-
mation is associated with the matched isolates. Thus, additional
studies are required to assess if C. jejuni clone SA is an emerging
pathogen in humans. Regardless, the results from this study
clearly indicate that clone SA is a significant threat to public
health, at least in the United States. At this stage, it is unknown if
C. jejuni clone SA is also a significant problem for other countries.
However, published data on Campylobacter-associated sheep
abortions from other regions of the world (e.g., New Zealand and
the United Kingdom) showed high genetic diversity and a lack of
predominant clones among the isolates (37, 53), suggesting that
the dominance of C. jejuni clone SA in sheep abortion might be a
situation unique to the United States.
How clone SA is transmitted to humans is not entirely clear,
but raw milk appeared to be the main source of infection for the
outbreak cases (Table 1). Besides raw milk, ruminants can also
transmit pathogenic Campylobacter to humans via other means,
including direct contact and environmental contamination of wa-
ter and produce (11, 26, 32, 59), which may explain the fact that
clone SA was also associated with a number of sporadic cases of
campylobacteriosis (Table 1). Given that red meat (beef and
lamb) is rarely contaminated by Campylobacter (33), it is unlikely
that it plays a significant role in the transmission of clone SA. The
raw-milk-associated outbreaks of human campylobacteriosis due
to clone SA (Table 1) clearly implicate cattle and milk as impor-
tant sources and/or transmission vehicles for C. jejuni clone SA.
Importantly, detection of clone SA in the human patients and the
raw milk implicated in the outbreak (Table 1) that occurred in
Pennsylvania in 2008 provides both epidemiological and genetic
evidence for food-borne transmission of clone SA via milk. Addi-
tionally, identification of clone SA in bovine stool samples during
several raw-milk-related outbreaks (Table 1) further highlights
the significance of ruminants in the epidemiology of human ill-
ness caused by this particular C. jejuni clone. The findings in this
study are consistent with previous reports that implicate Campy-
lobacter as the most common cause of milk-borne disease out-
breaks in the United States (43) and unpasteurizedmilk and asso-
ciated dairy products as major sources for Campylobacter
infections in humans (19, 32, 44).
The observation that clone SA has become a persistently pre-
dominant cause of Campylobacter-associated ovine abortions in
the United States (48, 53) is quite intriguing and suggests that the
clone is ecologically well adapted and pathologically hypervirulent
in ruminants. Also, clone SA was detected in healthy sheep and
cattle and abortion cases in cows and goats, indicating that the
clone is present in the ruminants as both a commensal and a
pathogen. The genetic diversity and the lack of a predominant
genotype among the C. jejuni isolates from healthy sheep (Fig. 2)
clearly contrast with the dominance of clone SA among the iso-
lates obtained from clinical abortion cases, further indicating that
clone SA is much more virulent than other C. jejuni strains to
pregnant sheep. The identification of C. jejuni clone SA in the bile
of healthy sheep suggests that it may colonize the gall bladder,
which would facilitate the persistence of clone SA in sheep. At
present, we do not know how prevalent clone SA is in bovine feces
or how frequently it contaminates milk. These questions are im-
portant for understanding the transmission of C. jejuni clone SA
and will be addressed in future studies.
To gain insights into the evolution of clone SA, eBURST anal-
ysis was performed using the MLST data on the entire set of iso-
lates within the ST-21 clonal complex. The analysis implied that
the ST-8 genotype, to which clone SA belongs, emerged from the
founding genotype, ST-21, of the clonal complex (Fig. 3). Evolu-
tion of ST-8 from ST-21 was likely accompanied by acquisition of
new genetic traits thatmay have enhanced its virulence and fitness
in ruminant animals and its transmissibility to humans. It should
be noted that evolutionary inferences made fromMLST could be
inaccurate and that further studies using high-resolution molec-
ular analysis (e.g., genome-wide single-nucleotide polymorphism
or whole-genome sequencing) should be performed to confirm
the results.What has driven the selection of clone SA remains to be
elucidated, but the fact that all clone SA isolates (regardless of their
sources of isolation) are resistant to tetracyclines, which are com-
monly used for prevention and treatment of sheep abortion in the
United States (25), suggests that the use of this class of antibiotics
might have facilitated the emergence of the clone in sheep. Other
factors, such as the use of vaccines nonhomologous to clone SA,
might also have facilitated the emergence of this pathogenic clone
in the sheep production systems. These possibilities remain to be
examined in future studies.
Currently there is no evidence implicating clone SA as a cause
of abortion in humans, but the possibility cannot be excluded,
considering the high virulence of clone SA in pregnant animals
and the fact thatC. jejuni has been implicated in human abortions,
stillbirths, and neonatal deaths (4, 5, 55). Laboratory challenge
studies using pregnant guinea pigs confirmed that clone SA was
highly abortifacient compared to other C. jejuni strains (7). Pre-
viously, it was reported that animal caretakers acquired C. jejuni
from aborting ewes and developed enteritis (18). In addition, re-
cent epidemiological studies have revealed a significant overlap
between human and sheep Campylobacter genotypes and identi-
fied contact with sheep as an important risk factor for human
infections (13, 51). In ewes that abort due to Campylobacter, a
large number of organisms are present in maternal and fetal tis-
sues/fluids, and environmental contamination occurs readily
(54), which may facilitate the zoonotic transmission of the abor-
tifacient strains to susceptible persons. Campylobacter-induced
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abortions in humans and sheep share similarities, including the
route of infection (via the intestinal tract), pathogenesis (bacter-
emia), and clinical outcomes (abortion, stillbirths, and premature
births), as well as the usually asymptomatic nature of infected
mothers (52). Considering the highly pathogenic and zoonotic
nature of clone SA, further studies are warranted to assess if thisC.
jejuni clone is involved in abortion in humans, in addition to
causing gastroenteritis.
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